Navigation Links
Jiangbo Pharmaceuticals Reports Results for Third Quarter of Fiscal Year 2010
Date:5/17/2010

by other companies. A table at the end of this press release provides a reconciliation of the non-GAAP adjusted financial information to the nearest GAAP measure.

About Jiangbo Pharmaceuticals, Inc.

Jiangbo Pharmaceuticals, Inc. is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its operations are located in Eastern China in an Economic Development Zone in Laiyang City, Shandong province. Jiangbo is a major pharmaceutical company in China producing both western and Chinese herbal-based medical drugs in tablet, capsule, granule, syrup and electuary (sticky syrup) form. http://www.jiangbopharma.com .

Safe Harbor Statement

Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the Company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to introduce, manufacture and distribute new drugs, improve operational efficiency, in-license or acquire new drugs, make required interest payment and NASDAQ listing. Actual results may differ materially from predicted resul
'/>"/>

SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
2. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
3. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
4. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
5. Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
6. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
7. Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results
8. DUSA Pharmaceuticals Announces Slate of Nominees for Election to the Board of Directors
9. Ferring Pharmaceuticals Announces Disco Icon Gloria Gaynor as National Spokesperson for EUFLEXXA(R)
10. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2010 First Quarter Earnings Conference Call on Monday, May 17, 2010 at 9:30 a.m. ET
11. Jazz Pharmaceuticals Announces Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... HILL, Conn. , July 2, 2015 ... Chief Executive Officer announced that Tamas Feitel ... Feitel joins Numotion after a highly successful 18 ... finance leadership roles driving strategy, profitability, and productivity to ... His most recent position was Chief Financial Officer for ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 ... of assets related to the ion channel biology platform ... previously been obtained as part of Pfizer,s 2011 acquisition ... Pfizer,s rights to the "Icagen" name and trademark.  XRPro ... comprehensive services for ion channel and transporter drug discovery, ...
(Date:7/2/2015)... TOKYO , July 2, 2015  Konica Minolta, ... today announced that it has acquired Sawae Technologica Ltda., ... Brazil , through its Brazilian healthcare ... . Local Brazil ... increasing population exceeding 200 million, significant healthcare ...
Breaking Medicine Technology:Numotion Names Tamas Feitel Chief Financial Officer 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3
... Making uninformed decisions in today,s new and ... kind of small missteps that briefly disrupt productivity ... negative media attention. Savvy pharmaceutical executives base direction-changing ... To support pharmaceutical vice presidents, directors, and ...
... UCB, a leading biopharmaceutical company at the forefront of ... Cimzia® (certolizumab pegol) at the American College of Gastroenterology ... from October 28 to November 2.   ... the role that inflammatory biomarkers may play in increasing ...
Cached Medicine Technology:Pharmaceutical Executives Use New Search Function for Data-Informed Decision-Making 2New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 2New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 3New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 4New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 5New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 6New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 7New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 8New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 9New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 10New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease 11
(Date:7/2/2015)... ... July 02, 2015 , ... AvePoint Public Sector, Inc., a wholly ... and devices, today announced it was named the recipient of the 2015 GTRA ConVurge ... given out by the Government Technology Research Alliance (GTRA), was presented June 29 during ...
(Date:7/2/2015)... ... ... arrests and fatalities spike on the 4th of July. In fact, because of drunk drivers, ... to being on the road. According to attorney David J. Maloney , the statistics ... deaths between 2007 and 2011 were caused by drunk driving over the 4th of July ...
(Date:7/2/2015)... Yorba Lind, CA (PRWEB) , ... July 02, 2015 , ... ... Dunne, PhD, QC manager, have adopted Lean methodology in their QC laboratory for enhanced ... Certified Lean Six Sigma Laboratory within the GE Healthcare Diagnostic Imaging network. ...
(Date:7/2/2015)... ... 2015 , ... As part of the celebration of its 70th anniversary, the ... its patients from all around the world for their continuous patronage of the world-class ... a dental tour (indeed, Thantakit is one of the foremost places for dental tourism ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... with nutritionally based weight-loss programs , was named No. 14 on ColoradoBiz ... this is the third year SlimGenics has been recognized. The award identifies outstanding ...
Breaking Medicine News(10 mins):Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 2Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 4Health News:Attorney David Maloney Stresses Safety through Sobriety 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 3Health News:Thailand's Longest Established International Dental Center Celebrates Its 70th Anniversary with Promos Galore 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 3
... , FRIDAY, Jan. 14 (HealthDay News) -- Researchers have ... risk of cardiovascular disease, while also noting that having ... once arteries become clogged. "Certain genes predispose to ... heart attack when you already have plaque build-up," said ...
... ongoing controversy about the appropriate age, frequency, and ... the upcoming 19th Annual Congress on Women,s Health, ... "Point-Counterpoint: The Mammography Controversy" will explore the relevant ... of Radiology, Magee-Womens Hospital, University of Pittsburgh School ...
... HealthDay Reporter , FRIDAY, Jan. 14 (HealthDay News) -- If ... you stand and sit may affect how you feel about ... an interview during these tough economic times, according to a ... Management at Northwestern University in Illinois found that undergraduates who ...
... -- Bacteria that prey on other bacteria may prove useful ... two types of predatory bacteria -- Micavibrio aeruginosavorus ... bacteria. "They actually have to consume other bacteria in ... ability to seek out other bacteria, invade them, grow in ...
... News) -- Obese black patients receive less weight reduction and ... study finds. The researchers at the Johns Hopkins University ... to find that white patients treated by black doctors were ... black patients treated by black doctors. "Our findings could ...
... , FRIDAY, Jan. 14 (HealthDay News) -- ... to become primary care doctors, who are expected to ... contends a new study from Johns Hopkins. They,re ... problems as diabetes, hypertension and high cholesterol, the study ...
Cached Medicine News:Health News:Blood Type O Associated With Less Risk for Heart Attack 2Health News:Blood Type O Associated With Less Risk for Heart Attack 3Health News:Mammography controversy to be explored at 19th Annual Congress on Women's Health 2Health News:To Nab That Job, Check Your Posture 2Health News:To Nab That Job, Check Your Posture 3Health News:Predatory Bacteria May Help Control Antibiotic-Resistant Germs 2Health News:Is Race a Factor in Obesity Counseling? 2Health News:Med School Grads May Not Be Ready for Primary Care 2
For the quantitative determination of total protein in serum. Linearity: 1-15 g/dl....
For the determination of urea nitrogen in human serum....
... for the quantitative determination of ... kinetic, lag phase of less ... linear phase of at least ... Linearity: 100 mg/dL (35.6 mmol/L ...
Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic. Wavelength: 340 nm. Linearity: 150 mg/dL (53.4 mmol/L urea) at 37C....
Medicine Products: